Agile Therapeutics | AGRX - Des Atouts



Des Atouts Changement Date
Adma Biologics USD 568.69M 10.31M 2025-09
Alterity Therapeutics Limited AUD 27.32M 6.07M 2023-06
Bayer EUR 104.54B 331M 2025-12
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Cassava Sciences USD 129.73M 5.65M 2025-09
Cipla INR 401.64B 27.77B 2025-09
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 97.84M 8.68M 2025-09
CSL USD 37.9B 1.5B 2025-12
Grifols EUR 23.29B 3.35M 2025-09
J&J USD 199.21B 6.39B 2025-12
Merck USD 129.55B 12.02B 2025-09
Pacira USD 1.26B 32.66M 2025-12
Pfizer USD 208.73B 2.64B 2025-09
TherapeuticsMD USD 40.13M 1.96M 2024-06